{"id":2117,"date":"2025-05-26T19:09:30","date_gmt":"2025-05-26T17:09:30","guid":{"rendered":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/"},"modified":"2025-11-12T13:08:13","modified_gmt":"2025-11-12T11:08:13","slug":"hepaxane","status":"publish","type":"page","link":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/","title":{"rendered":"Hepaxane"},"content":{"rendered":"<div id=\"block_cd5b908ae96fbe4b5272012da0d11813\" class=\"hero-block alignfull\" style=\"background-image: url(https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hero-section.jpg)\">\n\t<div class=\"wrap\">\n\t\t\t\t<h1 class=\"entry-title\">Hepaxane<sup>\u00ae<\/sup><\/h1>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_6da248017bdae314489dc5ef63177b3b\" class=\"secondary-menu-block alignfull\" style=\"\">\n<ul class=\"secondary-menu-container\">\n\t\t\t<li class=\"secondary-menu-item\">\n\t\t\t<a class=\"secondary-menu-item__content\" href=\"#hepaxane\">Hepaxane<sup>\u00ae<\/sup><\/a>\n\t\t<\/li>\n\t\t\t\t<li class=\"secondary-menu-item\">\n\t\t\t<a class=\"secondary-menu-item__content\" href=\"#notice\">Packungsbeilage<\/a>\n\t\t<\/li>\n\t\t\t<\/ul>\n\t<\/div>\n\n\n<div id=\"block_8ba74305d0fba1a5e0bb4ce173beb7ff\" class=\"inner-hero-block product-img-vertical-85 alignfull hero-mbl-column\" style=\"background-image: url(https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/03\/hepaxane-bg.svg)\">\n<div class=\"anchor-div\"><\/div>\n\n\t\t\t\n\t\t<div class=\"inner-hero-bg-mbl\" style=\"background-image: url(https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/03\/hepaxane-bg.svg); aspect-ratio:393\/200; min-height:200px;\">\n\t\t<div class=\"img-gal-container\">\n\t\t\t<div class=\"swiper image-gallery\"><div class=\"swiper-wrapper\"><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-20@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-20@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-20@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-60@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-60@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-60@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-80@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-80@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-80@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><\/div><div class=\"swiper-pagination-img-gallery\"><\/div><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t<div class=\"wrap\" style=\"flex-direction: row-reverse;\">\n\t<div class=\"swiper image-gallery\"><div class=\"swiper-wrapper\"><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-20@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-20@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-20@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-60@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-60@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-60@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><div class=\"swiper-slide\"><img loading=\"lazy\" decoding=\"async\" width=\"610\" height=\"656\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-80@2x.png\" class=\"slide-image\" alt=\"EFFIK\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-80@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-80@2x-279x300.png 279w\" sizes=\"auto, (max-width: 610px) 100vw, 610px\" \/><\/div><\/div><div class=\"swiper-pagination-img-gallery\"><\/div><\/div>\t<div class=\"content-container\" style=\"text-align: left;\">\n\t\t\t\t\t\t\t\t\t<div class=\"section-content font-medium\" style=\"max-width: 550px; align-self: flex-start;\"><p><strong>Nach operativen Eingriffen oder bei Bettl\u00e4gerigkeit besteht die Gefahr der Bildung von tiefen Beinvenenthrombosen und Lungenembolien.<\/strong><br \/>\n&nbsp;<br \/>\n<strong>Hepaxane<sup>\u00ae<\/sup> wird zur Vorbeugung gegen die Entstehung von Thrombosen angewendet. Enoxaparin, der Wirkstoff von Hepaxane\u00ae, ist ein <strong>niedermolekulares Heparin, welches den Vorgang der Blutgerinnung bremst und so der Bildung von Blutgerinnseln entgegenwirkt.<\/strong><\/p>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>\n<style>\n\t.inner-hero-block {\n\t\t@media (min-width: 768px) {\n\t\taspect-ratio: 1440 \/ 390; \n\t\tmin-height: 390px;\n\t\t}\n\t}\n<\/style>\n\n\n<div id=\"hepaxane\" class=\"featured-text-block\">\n\t<div class=\"wrap\">\t\t<div class=\"featured-box\" style=\"background:#9a000c; box-shadow:10px 10px 0px 0px rgba(154, 0, 12, 0.30);\"><h2 class=\"featured-title\">Hepaxane<sup>\u00ae<\/sup>: Ihr Enoxaparin-Biosimilar zur Thrombose-Prophylaxe und -Therapie.<\/h2><\/div>\t<\/div>\n<\/div>\n\n\n<div id=\"block_e6287bdb51a8242ba1a56e86a154ee0c\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap\">\t\t<div class=\"product-left-content left-width-one-third\">\n\t\t\t\t\t\t\t<p>Hepaxane<sup>\u00ae<\/sup> ist indiziert bei<\/p>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-third\">\n\t\t\t<div class=\"hepaxane-table\">\n<div class=\"hepaxane-table-row\"><strong>Prophylaxe thromboembolischer Erkrankungen ven\u00f6sen Ursprungs<\/strong>, speziell in der orthop\u00e4dischen oder allgemeinen Chirurgie.<\/div>\n<div class=\"hepaxane-table-row\">\n<p><strong>Prophylaxe von thromboembolischen Erkrankungen ven\u00f6sen Ursprungs<\/strong> bei bettl\u00e4gerigen medizinischen Patienten mit einer akuten Erkrankung, wie:<\/p>\n<ul>\n<li>Herzinsuffizienz (NYHA Klasse III oder IV).<\/li>\n<li>Akute respiratorische Insuffizienz.<\/li>\n<li>Akute infekti\u00f6se oder rheumatische Erkrankungen verbunden mit einem\/ anderen thromboembolischen Risikofaktor\/en.<\/li>\n<\/ul>\n<\/div>\n<div class=\"hepaxane-table-row\"><strong>Behandlung der instabilen Angina<\/strong> pectoris und des Nicht-Q-Wellen Myokardinfarktes als Kombinationsbehandlung mit Acetylsalicyls\u00e4ure.<\/div>\n<div class=\"hepaxane-table-row\"><strong>Therapie des akuten<\/strong> ST-Hebungs-Myokardinfarktes (STEMI).<\/div>\n<div class=\"hepaxane-table-row\"><strong>Behandlung der tiefen Venenthrombose<\/strong> mit oder ohne Lungenembolie.<\/div>\n<div class=\"hepaxane-table-row\"><strong>Thromboseprophylaxe<\/strong> im extrakorporalen Kreislauf bei der H\u00e4modialyse.<\/div>\n<\/div>\n\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_bb7c499c0f6f58b6cb6e0564091ad348\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap has-noborder\">\t\t<div class=\"product-left-content left-width-one-third\">\n\t\t\t\t\t\t\t<p>Die Hepaxane<sup>\u00ae<\/sup>-Spritze<\/p>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-third\">\n\t\t\t<div class=\"right-content-nocolumns body_16_regular pt0\">\n<ul>\n<li><strong>Praktische Fertigspritze<\/strong> mit manuellem Nadelschutzsystem<\/li>\n<li><strong>Der manuelle Vorschub<\/strong> verhindert ein Versagen des Sicherheitsmechanismus<\/li>\n<\/ul>\n<\/div>\n<div class=\"right-content-nocolumns\"><img decoding=\"async\" class=\"alignleft size-large wp-image-1583\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/Hepaxane-Injection-DE-1-1024x317.png\" alt=\"\" width=\"100%\" height=\"auto\" \/><\/div>\n<div class=\"right-content-half-columns\">\n<div class=\"right-content-half-columns-left\">\n<p>Dosierungsalgorithmen f\u00fcr die Verabreichung von Hepaxane<sup>\u00ae<\/sup>.<\/p>\n<p><a class=\"blue-button\" href=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/Hepaxane_Dosing_Card_DE.pdf\" target=\"_blank\" rel=\"noopener\">Herunterladen<\/a><\/p>\n<\/div>\n<div class=\"right-content-half-columns-right\">\n<p>Anwendungshinweise f\u00fcr Patienten.<\/p>\n<p><a class=\"blue-button\" href=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/Hepaxane_Patient_Block_DE.pdf\" target=\"_blank\" rel=\"noopener\">Herunterladen<\/a><\/p>\n<\/div>\n<\/div>\n\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n\n<p class=\"heading_28_semibold mtb48\">Die Vorteile von Hepaxane<sup>\u00ae<\/sup><\/p>\n\n\n<div id=\"block_f4b72e034d80e7395c8cb4854148e4b8\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap\">\t\t<div class=\"product-left-content left-width-one-third\">\n\t\t\t\t\t\t\t<ol>\n<li><strong>Biosimilar<\/strong> Enoxaparin \u2028mit <strong>vergleichbarer Bioverf\u00fcgbarkeit wie das Referenzprodukt zu niedrigeren Kosten.<\/strong><sup>1<\/sup><\/li>\n<\/ol>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-third\">\n\t\t\t<div class=\"right-content-nocolumns body_16_regular pt0\">\n<p><strong>Biosimilars<\/strong>, biologische Arzneimittel, die den von Swissmedic zugelassenen Referenzprodukten \u00e4hneln, haben in der Regel eine Proteinstruktur und werden mithilfe von lebenden Organismen hergestellt. <strong>Sie bieten mehrere Vorteile:<\/strong><\/p>\n<ul>\n<li><strong>Zug\u00e4nglichkeit und Wirtschaftlich: Senkung der Behandlungskosten und mehr Auswahl f\u00fcr Patienten.<\/strong><\/li>\n<li><strong>Wirksamkeit und Sicherheit: Nachgewiesene Gleichwertigkeit mit dem Referenzarzneimittel.<\/strong><\/li>\n<li><strong>Hohe Qualit\u00e4tsstandards: Unterliegen strengen Qualit\u00e4tskontrollen.<\/strong><\/li>\n<\/ul>\n<\/div>\n<div class=\"right-content-nocolumns body_16_regular\"><img decoding=\"async\" class=\"alignleft size-large wp-image-1602\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/Hepaxane-Graph-DE-1024x391.png\" alt=\"\" width=\"100%\" height=\"auto\" \/><\/div>\n\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_ec61d964671f3fa255c4faceb3501659\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap\">\t\t<div class=\"product-left-content left-width-one-third\">\n\t\t\t\t\t\t\t<ol start=\"2\">\n<li><strong>Preisvorteil<\/strong> f\u00fcr Patienten und Gesundheitswesen<\/li>\n<\/ol>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-third\">\n\t\t\t<div class=\"right-content-nocolumns body_16_regular pt0\">\n<ul>\n<li>Hepaxane<sup>\u00ae<\/sup>: Publikumspreis (PP) im Vergleich zum Referenzpr\u00e4parat Enoxaparin.<\/li>\n<\/ul>\n<\/div>\n<div class=\"right-content-nocolumns body_16_regular\"><img decoding=\"async\" class=\"alignleft size-large wp-image-1608\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/Hepaxane-price-DE-1024x380.png\" alt=\"\" width=\"100%\" height=\"auto\" \/><\/div>\n<div class=\"right-content-nocolumns body_16_regular\">\n<ul>\n<li>\u00d6konomische Entlastung von Patienten sowie des Schweizer Gesundheitssystems.<\/li>\n<\/ul>\n<\/div>\n\t\t<\/div>\n\t\t\t\t\t<div class=\"full-width-bottom-text\">\n\t\t\t\t<p>* Der Preis f\u00fcr die Spritzen im 10er-Pack pro Einheit<br \/>\n** Der Preis f\u00fcr die Spritzen im 50er-Pack pro Einheit<\/p>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_5a6b43075eb27e2164d69ce0922182c1\" class=\"product-content-2cols-block\" style=\"\">\n\t<div class=\"wrap\">\t\t<div class=\"product-left-content left-width-one-third\">\n\t\t\t\t\t\t\t<ol start=\"3\">\n<li><strong>Geringeres Risiko<\/strong> f\u00fcr Lieferengp\u00e4sse durch verschiedene Wirkstofflieferanten sowie Produktion in Italien<sup>*<\/sup><\/li>\n<\/ol>\n\t\t\t\t\t<\/div>\n\t\t<div class=\"product-right-content left-width-one-third\">\n\t\t\t<div class=\"right-content-columns pt0\">\n<div class=\"right-content-left-col body_16_regular pt0\">\n<p><b>Hepaxane<sup>\u00ae<\/sup>: Ein zuverl\u00e4ssiger Partner in der Thrombose-Prophylaxe und -Therapie<br \/>\n<\/b><\/p>\n<ul>\n<li>Seit Beginn der Enoxaparin Produktion (2006) keine einzige Produktionsunterbrechung<\/li>\n<li>&gt; 300 Mio. verkaufte Spritzen mit Enoxaparin-Na von Chemi weltweit<sup>***<\/sup>.<\/li>\n<li>Die Qualit\u00e4tskontrolle und Pr\u00fcfung sowie die Verpackung von Enoxaparin-Natrium werden von Chemi\/Italfarmaco in Mailand, Italien durchgef\u00fchrt.<\/li>\n<\/ul>\n<\/div>\n<div class=\"right-content-right-col body_16_regular pt0\"><img decoding=\"async\" class=\"alignleft size-full wp-image-1028\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x.png\" alt=\"\" width=\"100%\" height=\"auto\" srcset=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x.png 610w, https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2024\/05\/Hepaxane-40@2x-279x300.png 279w\" sizes=\"(max-width: 610px) 100vw, 610px\" \/><\/div>\n<\/div>\n\t\t<\/div>\n\t\t\t\t\t<div class=\"full-width-bottom-text\">\n\t\t\t\t<p>*** Der in Hepaxane<sup>\u00ae<\/sup> enthaltene Wirkstoff Enoxaparin-Natrium wird von Chemi, Italfarmaco hergestellt. Weltweit sind im Zeitraum 2006-2024 bereits \u00fcber 314\u2018058\u2018310 Spritzen des von Chemi hergestellten Enoxaparin-Natrium verordnet worden (Stand 03.04.2024).<\/p>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/div>\n\n\n<div id=\"block_a48a60482d6c0621a6379c923982d509\" class=\"effilevo-block\" style=\"\">\n\t<div class=\"wrap\">\n\t\t<div id=\"product\" class=\"product-box-container\"><div class=\"product-info\"><p><img decoding=\"async\" class=\"size-large wp-image-1627 aligncenter\" src=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/Hepaxane-Dose-DE-1024x703.jpg\" alt=\"\" width=\"100%\" height=\"auto\" \/><\/p>\n<p class=\"body_16_regular\" style=\"text-align: center;\">Die Farbcodes sind an die jeweiligen Dosierungen angepasst.<\/p>\n<\/div><\/div><div id=\"notice\" class=\"leaflet-container\"><div class=\"leaflet-item\"><div class=\"leaflet-title\">Abgek\u00fcrzte Fachinformation Hepaxane<sup>\u00ae<\/sup>, Injektionsl\u00f6sung.<\/div><a class=\"blue-button\" href=\"https:\/\/effik.ch\/hcp\/wp-content\/uploads\/sites\/2\/2025\/06\/RCP_Hepaxane_DE.pdf\">Hier herunterladen<\/a><\/div><div class=\"disclaimer\"><p>AUSF\u00dcHRLICHE ANGABEN SIND IN DER FACHINFORMATION AUF DER SWISSMEDIC PLATTFORM PUBLIZIERT <strong><a href=\"https:\/\/www.swissmedicinfo.ch\" target=\"_blank\" rel=\"noopener\">WWW.SWISSMEDICINFO.CH<\/a><\/strong>.<\/p>\n<p><strong>Zulassungsinhaberin:<\/strong> EFFIK SA, 1260 NYON.<\/p>\n<\/div><\/div><div class=\"references\"><p>1. Febbraro S, et al. Bioavailability study of Enoxaparin Sodium Chemi (80 mg\/0.8 mL) and Clexane (80 mg\/0.8 mL) subcutaneous injection in healthy adults. Int J Clin Pharmacol Ther. 2021 Nov;59(11):734-744.<\/p>\n<\/div>\t<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"Die Vorteile von Hepaxane\u00ae","protected":false},"author":1,"featured_media":0,"parent":1231,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":{"2":"type-page","4":"hentry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hepaxane - EFFIK HCP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hepaxane - EFFIK HCP\" \/>\n<meta property=\"og:description\" content=\"Die Vorteile von Hepaxane\u00ae\" \/>\n<meta property=\"og:url\" content=\"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/\" \/>\n<meta property=\"og:site_name\" content=\"EFFIK HCP\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-12T11:08:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/\",\"url\":\"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/\",\"name\":\"Hepaxane - EFFIK HCP\",\"isPartOf\":{\"@id\":\"https:\/\/effik.ch\/hcp\/#website\"},\"datePublished\":\"2025-05-26T17:09:30+00:00\",\"dateModified\":\"2025-11-12T11:08:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/effik.ch\/hcp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hepaxane\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/effik.ch\/hcp\/#website\",\"url\":\"https:\/\/effik.ch\/hcp\/\",\"name\":\"EFFIK HCP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/effik.ch\/hcp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hepaxane - EFFIK HCP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/","og_locale":"de_DE","og_type":"article","og_title":"Hepaxane - EFFIK HCP","og_description":"Die Vorteile von Hepaxane\u00ae","og_url":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/","og_site_name":"EFFIK HCP","article_modified_time":"2025-11-12T11:08:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/","url":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/","name":"Hepaxane - EFFIK HCP","isPartOf":{"@id":"https:\/\/effik.ch\/hcp\/#website"},"datePublished":"2025-05-26T17:09:30+00:00","dateModified":"2025-11-12T11:08:13+00:00","breadcrumb":{"@id":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/effik.ch\/hcp\/hamatologieund-kardiologie\/thromboseprophylaxe-und-therapie\/hepaxane\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/effik.ch\/hcp\/"},{"@type":"ListItem","position":2,"name":"Hepaxane"}]},{"@type":"WebSite","@id":"https:\/\/effik.ch\/hcp\/#website","url":"https:\/\/effik.ch\/hcp\/","name":"EFFIK HCP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/effik.ch\/hcp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/2117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/comments?post=2117"}],"version-history":[{"count":8,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/2117\/revisions"}],"predecessor-version":[{"id":2605,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/2117\/revisions\/2605"}],"up":[{"embeddable":true,"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/pages\/1231"}],"wp:attachment":[{"href":"https:\/\/effik.ch\/hcp\/wp-json\/wp\/v2\/media?parent=2117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}